A new study suggests people who exercise in the early morning have lower risks of coronary artery disease, high blood pressure, diabetes and obesity.

A new study finds children exposed to type 1, type 2 or gestational diabetes in the womb have a slightly increased risk of developing epilepsy.

HealthDay takes you on a tour of the Yale Teaching Kitchen, where patients with diabetes, heart disease, obesity and more learn to cook for life.

UK researchers report higher complication rates from cosmetic Botox injections among patients with chronic conditions like type 1 diabetes and thyroid disease.

In a large new study, statins significantly lowered the risk of death and major heart events in people with type 2 diabetes — regardless of their heart risk level.

A new study suggests GLP-1 medications may reduce the need for CPAP machines in people with obesity, diabetes and sleep apnea.

A new study finds people taking GLP-1 drugs are up to 29% more likely to develop a chronic cough – even if they aren’t diagnosed with acid reflux.

A new study finds people with type 2 diabetes are four times more likely to develop significant hearing loss over time.

CMK syndrome links heart, kidney and metabolic risk factors and the American Heart Association says it’s extremely common in U.S. adults.

A new study finds pot users are nearly 4 times more likely to develop type 2 diabetes compared to the general public.

A new study finds nearly half of people ages 15 and older have diabetes and don’t know it.

A new study finds eating too many French fries ups the odds of type 2 diabetes but swapping them for whole grains offers protection from the common blood sugar condition.

A new study finds exposure to PFAS may disrupt the body’s metabolism -- increasing the risk for type 2 diabetes.

People with diabetes who use GLP-1 receptor agonists like semaglutide are more likely to develop neovascular age-related macular degeneration, a new study finds.

A new study finds women taking GLP-1 Receptor agonists were significantly less likely to develop obesity-related cancers.